Heimdall Insights

Global Gout Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Gout Therapeutics Market was valued at $3.4 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.8% CAGR, to an estimated market size of $4.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global gout therapeutics market includes pharmacological treatments and management strategies for gout, a form of inflammatory arthritis caused by hyperuricemia. The scope covers urate-lowering therapies (ULTs) such as xanthine oxidase inhibitors and uricosurics, anti-inflammatory agents like NSAIDs, colchicine, and corticosteroids, and biologic therapies (e.g., IL-1 inhibitors) used for acute flare management and chronic disease control.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Gout Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Urate-Lowering Therapy (ULT)
  • NSAIDs
  • Others (Colchicine, Biologics, Steroids)